We are studying the heart to gather new information regarding how the heart functions as a pump. We hope to learn how the pumping ability of the heart is maintained in health and disease. Patients selected are scheduled for a routine heart catheterization to determine the severity of their heart valve problem. Patients who participate will undergo additional studies after the completion of the routine heart catheterization which demonstrated no blockages in the coronary arteries. These additional studies will include: 1) placement of a temporary heart pacemaker, 2) placement of a special pressure sensing catheter into the heart, 3) placement of a catheter into the coronary sinus, 4) infusion of 3H-norepinephrine, 5) multiple blood samples (a total of not more than 150 ccs, or 3 tablespoons), 6) an injection into your vein of technetium-99m with drugs to increase or decrease your blood pressure (methoxamine or nitroprusside), 7) a dobutamine echocardiogram, 8) a blood test to measure the cytokine and catecholamine levels in your blood, and 9) heart muscle biopsies. A more complete explanation follows.A temporary pacing wire will be used to keep your heart rate constant during the study. A special catheter will be inserted into the major pumping chamber of your heart to measure precise pressure in it. A catheter will also be inserted through a small, flexible catheter into the vein (coronary sinus) that drains blood from your heart to measure the blood flow to your heart. The study procedure will involve infusion by vein of a radioisotope (3H-norepinephrine) that will be maintained for 60 minutes.Multiple blood samples will be drawn from the sheath in the artery in your leg and from the catheter in the vein that drains the blood from your heart at specific times during the infusion and for 20 minutes following completion of the infusion to measure the activity of the sympathetic nervous system both in the whole body and the heart. Then, your heart will be paced at 100 beats per minute. Measurement of precise pressures in the pumping chamber and movies of your heart will be acquired using another radioisotope (technetium-99m) injected by vein both at rest and with drugs to increase or decrease your blood pressure (methoxamine or nitroprusside) within a range that it might vary normally during the day. It is estimated that 150 minutes will be required for the additional portion of the heart catheterization to be completed. On a separate day, a dobutamine echocardiogram will be done. This test uses sound waves to create moving pictures of the heart. Pictures of the heart will be taken at rest and while a medication, dobutamine, is infused into a vein. This test allows us to see how the heart muscle and heart valves are working at rest and under periods of stress or exertion. All women of child bearing potential will have a pregnancy test before any study clinic visits. If there is a severe leak of the mitral valve and heart valve surgery is needed, patients will be referred for surgical procedure to repair the mitral valve. This is the optimal surgical procedure for this heart valve problem. During the operation, small biopsy specimens of the heart muscle will be taken to determine whether any structural change or damage to the heart muscle has occurred as a result of the heart problem. We would like to follow the patients who do undergo surgery to repair their mitral valve during the first year of recovery. This would involve an echocardiogram and MUGA scan approximately three and twelve months after surgery and clinic visits to assess each patients health status.

Project Start
1999-12-01
Project End
2001-02-28
Budget Start
Budget End
Support Year
40
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Robarge, Jason D; Desta, Zereunesay; Nguyen, Anne T et al. (2017) Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer. Breast Cancer Res Treat 161:453-461
Crane, Natania A; Jenkins, Lisanne M; Bhaumik, Runa et al. (2017) Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI. Brain 140:472-486
Hertz, Daniel L; Speth, Kelly A; Kidwell, Kelley M et al. (2017) Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast Cancer Res Treat 165:659-668
Hertz, D L; Kidwell, K M; Seewald, N J et al. (2017) Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer. Pharmacogenomics J 17:521-527
Kadakia, Kunal C; Kidwell, Kelley M; Seewald, Nicholas J et al. (2017) Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors. Breast Cancer Res Treat 164:411-419
Spengler, Erin K; Kleiner, David E; Fontana, Robert J (2017) Vemurafenib-induced granulomatous hepatitis. Hepatology 65:745-748
Heidemann, Lauren; Law, James; Fontana, Robert J (2017) A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury. Dig Dis Sci 62:615-625
Law, Ian H; Alam, Osman; Bove, Edward L et al. (2016) Follow-Up of a Prospective Surgical Strategy to Prevent Intra-Atrial Reentrant Tachycardia After the Fontan Operation. Circ Arrhythm Electrophysiol 9:
Schrepf, Andrew; Harper, Daniel E; Harte, Steven E et al. (2016) Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study. Pain 157:2217-2225
As-Sanie, Sawsan; Kim, Jieun; Schmidt-Wilcke, Tobias et al. (2016) Functional Connectivity is Associated With Altered Brain Chemistry in Women With Endometriosis-Associated Chronic Pelvic Pain. J Pain 17:1-13

Showing the most recent 10 out of 1380 publications